DK0979654T3 - Emulsion lotions with active vitamin D3 - Google Patents

Emulsion lotions with active vitamin D3

Info

Publication number
DK0979654T3
DK0979654T3 DK99937875T DK99937875T DK0979654T3 DK 0979654 T3 DK0979654 T3 DK 0979654T3 DK 99937875 T DK99937875 T DK 99937875T DK 99937875 T DK99937875 T DK 99937875T DK 0979654 T3 DK0979654 T3 DK 0979654T3
Authority
DK
Denmark
Prior art keywords
active vitamin
nonionic surfactant
weight
content
parts
Prior art date
Application number
DK99937875T
Other languages
Danish (da)
Inventor
Kazuya Takanashi
Seiji Mochizuki
Wataru Akasofu
Katsumi Sakurai
Noriaki Okamura
Takao Fujii
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Application granted granted Critical
Publication of DK0979654T3 publication Critical patent/DK0979654T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention provides a pharmaceutical composition for local administration in the form of an emulsion that contains active vitamin D3 and is suitable for application to areas with (the) hair, while also having satisfactory pharmacological activity, primary drug stability and physical stability. This lotion contains (a) a therapeutically effective amount of active vitamin D3, (b) an oil phase component containing a solid oil component comprising white Petrolatum and a higher alcohol and a liquid oil component comprising squalane, (c) an aqueous phase component containing ionic polysaccharide, and (d) nonionic surfactant; wherein, (1) the content of said ionic polysaccharide is 0.3-1.0 parts by weight of the entire preparation, (2) the content of said higher alcohol is 0.2-1.0 parts by weight of the entire preparation, and (3) the HLB of said nonionic surfactant is 10 or more.
DK99937875T 1998-03-04 1999-03-03 Emulsion lotions with active vitamin D3 DK0979654T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5201998 1998-03-04

Publications (1)

Publication Number Publication Date
DK0979654T3 true DK0979654T3 (en) 2006-01-02

Family

ID=12903112

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99937875T DK0979654T3 (en) 1998-03-04 1999-03-03 Emulsion lotions with active vitamin D3

Country Status (24)

Country Link
US (1) US6187763B1 (en)
EP (1) EP0979654B1 (en)
JP (1) JP4046363B2 (en)
KR (1) KR100491202B1 (en)
CN (1) CN1152689C (en)
AT (1) ATE302608T1 (en)
AU (1) AU744712B2 (en)
BR (1) BR9904847B1 (en)
CA (1) CA2288694C (en)
CZ (1) CZ298971B6 (en)
DE (1) DE69926843T2 (en)
DK (1) DK0979654T3 (en)
ES (1) ES2245511T3 (en)
HK (1) HK1029933A1 (en)
HU (1) HU226610B1 (en)
IL (1) IL132750A (en)
MY (1) MY122390A (en)
NO (1) NO328086B1 (en)
NZ (1) NZ500769A (en)
PL (1) PL192825B1 (en)
RU (1) RU2207843C2 (en)
SK (1) SK285439B6 (en)
TW (1) TWI240635B (en)
WO (1) WO1999044617A1 (en)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
HU230045B1 (en) * 1999-04-23 2015-06-29 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Pharmaceutical composition for dermal use
DE19955684A1 (en) * 1999-11-19 2001-05-23 Hilti Ag Anchor rod for anchoring with organic and / or inorganic mortar compounds
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US6881427B2 (en) * 2002-01-31 2005-04-19 Alticor Inc. Topical anti-inflammatory composition containing linseed and licorice extracts
US20030185915A1 (en) * 2002-03-28 2003-10-02 Jaime Carlo Synergetic composition for the treatment of psoriasis and other skin disorders and method therefor
WO2004037225A2 (en) 2002-10-25 2004-05-06 Foamix Ltd. Cosmetic and pharmaceutical foam
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20060018937A1 (en) * 2002-10-25 2006-01-26 Foamix Ltd. Steroid kit and foamable composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
WO2007054818A2 (en) 2005-05-09 2007-05-18 Foamix Ltd. Foamable vehicle and pharmaceutical compositions thereof
NZ563560A (en) * 2005-06-01 2009-11-27 Stiefel Res Australia Pty Ltd Vitamin formulation for treating a dermatological skin disorder
US8574568B2 (en) 2005-11-07 2013-11-05 Kaneka Corporation Reduced coenzyme Q10-containing composition comprising a surfactant which is stable against oxidation and method for stabilization by mixing with surfactant(s)
FR2893847B1 (en) * 2005-11-30 2010-10-29 Galderma Sa SPRAY COMPOSITION COMPRISING VITAMIN D DERIVATIVE AND OILY PHASE
ES2625112T3 (en) 2006-01-30 2017-07-18 Maruho Co., Ltd. Oil-in-water emulsion lotion containing 22-oxa-1 alpha, 25-dihydroxyvitamin D3 and method of treating a skin disease using the same
ES2530390T3 (en) * 2006-07-05 2015-03-02 Foamix Pharmaceuticals Ltd Foaming vehicle of carboxylic acid and pharmaceutical compositions thereof
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
CA2712120A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US8470304B2 (en) 2009-08-04 2013-06-25 Avidas Pharmaceuticals Llc Therapeutic vitamin D sun-protecting formulations and methods for their use
WO2011064631A1 (en) 2009-10-02 2011-06-03 Foamix Ltd. Surfactant-free, water-free, foamable compositions and breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
WO2012127037A2 (en) * 2011-03-24 2012-09-27 Leo Pharma A/S A composition comprising lipid nanoparticles and a corticosteroid or vitamin d derivative
CA2877102C (en) * 2011-06-29 2020-06-30 Avidas Pharmaceuticals Llc Topical formulations including lipid microcapsule delivery vehicles and their uses
NZ596015A (en) * 2011-10-26 2014-04-30 Anzamed Internat Ltd Method and composition for the treatment of pain and/or inflammation
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
CN114159567B (en) * 2020-09-10 2023-03-31 南京海融医药科技股份有限公司 A suspension gel for treating dermatoses

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60174707A (en) * 1984-02-21 1985-09-09 Kanebo Ltd Hair cosmetic
CA1272953A (en) * 1984-10-08 1990-08-21 Yuji Makino Pharmaceutical composition for external use containing active-type vitamin d.sub.3
JPS61212515A (en) * 1985-03-16 1986-09-20 Taisho Pharmaceut Co Ltd Ointment for hemorrhoid
JPH04230317A (en) * 1990-12-27 1992-08-19 Lion Corp Milky lotion-like composition
JP3480956B2 (en) * 1992-10-16 2003-12-22 株式会社コーセー External preparation for skin
GB9226860D0 (en) * 1992-12-23 1993-02-17 Leo Pharm Prod Ltd Novel treatment
KR100221045B1 (en) 1993-09-01 1999-09-15 야스이 쇼사꾸 1 alpha, 24-(oh)2-vitamin d3 emulsion composition
JP3839502B2 (en) 1994-03-03 2006-11-01 帝人株式会社 Eczema / dermatitis group treatment
JPH08295628A (en) * 1995-04-27 1996-11-12 Teijin Ltd External agent for treatment of alopecia
JPH09249555A (en) * 1996-03-12 1997-09-22 Kowa Co Emulsive lotion

Also Published As

Publication number Publication date
PL192825B1 (en) 2006-12-29
EP0979654A1 (en) 2000-02-16
NZ500769A (en) 2001-04-27
MY122390A (en) 2006-04-29
IL132750A (en) 2004-01-04
US6187763B1 (en) 2001-02-13
EP0979654A4 (en) 2002-05-08
PL336621A1 (en) 2000-07-03
ES2245511T3 (en) 2006-01-01
CZ390099A3 (en) 2000-03-15
KR20010012244A (en) 2001-02-15
CA2288694C (en) 2009-11-17
HUP0002547A3 (en) 2001-03-28
CN1152689C (en) 2004-06-09
KR100491202B1 (en) 2005-05-25
SK151499A3 (en) 2000-09-12
WO1999044617A1 (en) 1999-09-10
HK1029933A1 (en) 2001-04-20
HUP0002547A2 (en) 2000-12-28
JP4046363B2 (en) 2008-02-13
AU744712B2 (en) 2002-02-28
RU2207843C2 (en) 2003-07-10
NO328086B1 (en) 2009-11-30
BR9904847B1 (en) 2010-07-13
CA2288694A1 (en) 1999-09-10
HU226610B1 (en) 2009-04-28
NO995367L (en) 1999-12-22
ATE302608T1 (en) 2005-09-15
DE69926843T2 (en) 2006-06-22
SK285439B6 (en) 2007-01-04
EP0979654B1 (en) 2005-08-24
CN1266370A (en) 2000-09-13
TWI240635B (en) 2005-10-01
DE69926843D1 (en) 2005-09-29
BR9904847A (en) 2000-09-05
CZ298971B6 (en) 2008-03-26
IL132750A0 (en) 2001-03-19
AU3274399A (en) 1999-09-20
NO995367D0 (en) 1999-11-03

Similar Documents

Publication Publication Date Title
DK0979654T3 (en) Emulsion lotions with active vitamin D3
BR9915298A (en) Liquid composition, and antiperspirant and / or deodorant cosmetic product.
DE69331335T2 (en) TOPICAL AND TRANSDERMAL DELIVERY SYSTEM USING SUBMICRON OIL BALLS
DK312583D0 (en) CORTICOID CONTAINING TOPIC APPLICATION
DE69904011T2 (en) Nanoemulsion based on sugar fatty acid esters and fatty alcohol ethers and their uses in cosmetics, dermatology and / or ophthalmology
FR2710854B1 (en) Oil-in-water emulsion usable for obtaining a cream.
FR2669225B1 (en) USE OF MEDICAGO SAPONINS FOR THE PREPARATION OF COSMETIC OR PHARMACEUTICAL COMPOSITIONS, ESPECIALLY DERMATOLOGICAL.
RU94035673A (en) Gel composition for use in cosmetics and dermatology
SE9800729D0 (en) New topical formulation I
DE69022314D1 (en) Stable emulsified tretinoin cream formulations.
EP0279136A3 (en) Cosmetic composition to retard the ageing of the skin, and application process
AU629445B2 (en) Improvements in or relating to topical compositions containing 1 alpha 25-dihydroxycholecalciferol
SE9704031D0 (en) Novel formulation
SE9800730D0 (en) New topical formulation II
NO944956D0 (en) Preparation for local application, method of preparation thereof, and use thereof
TW328049B (en) Penciclover/propylene glycol composition
GB2362105A (en) Aciclovir compositions containing dimethicone
ES2130164T3 (en) PHARMACEUTICAL COMPOSITION FOR TOPIC APPLICATION CONTAINING DITRANOL AND PREPARATION PROCEDURE.
TH39558A3 (en) Lotion emulsion containing the active vitamin D3.
AR022069A1 (en) VITAMIN EMULSION LOTION IN D3 ACTIVE
MX9602270A (en) Orally applicable pharmaceutical composition.
CA2583638A1 (en) Skin care emulsion composition comprising an epichlorohydrin crosslinked glyceryl starch